{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":47,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":47,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"c2162fb467e9","filters":{"venue":"Blood Cancer Discovery"}},"results":[{"id":"W2999773798","doi":"10.1158/0008-5472.bcd-19-0041","title":"Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; KWF Kankerbestrijding; China Scholarship Council","keywords":"Lymphoblastic Leukemia; Somatic evolution in cancer; Cancer research; Medicine; Biology; Leukemia; Genetics; Oncology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.0106784456143328,"gpt":0.258021045144686,"spread":0.2473425995303533,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009249105,0.0001721788,0.0003539228,0.000176316,0.00003025899,0.00002072221,0.0001025315,0.0001117518,0.0001028992],"category_scores_gemma":[0.0001266065,0.0001547211,0.00007197313,0.0004369278,0.00006065632,0.0001813234,0.0001010075,0.00020247,0.000007918352],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005065639,"about_ca_system_score_gemma":0.002489612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003602316,"about_ca_topic_score_gemma":0.0000477839,"domain_scores_codex":[0.9983335,0.00004210714,0.0003732792,0.0003804827,0.0005683471,0.0003022907],"domain_scores_gemma":[0.9993039,0.0001704442,0.0001182743,0.0001379035,0.00008156353,0.0001879028],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001389614,0.000149661,0.9896543,0.0006948644,0.0002303609,0.0003147413,0.0004651987,0.0007731752,0.005166321,0.0002908841,0.0006400276,0.0002308579],"study_design_scores_gemma":[0.01561787,0.0006336441,0.9708479,0.0002025428,0.0007621213,0.000152955,0.0002250863,0.009433391,0.001762987,0.00009853164,0.00002635918,0.0002366032],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962891,0.001229014,0.0008595472,0.0007955423,0.00008157064,0.0002880311,0.0002781449,0.00002408016,0.0001550243],"genre_scores_gemma":[0.9982197,0.000534491,0.0001268927,0.0003411985,0.0004622483,0.00005842602,0.00006895378,0.00002859405,0.0001595198],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01880638,"threshold_uncertainty_score":0.6309343,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387128075","doi":"10.1158/2643-3230.bcd-23-0049","title":"IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Narodowa Agencja Wymiany Akademickiej","keywords":"Hypogammaglobulinemia; Medicine; Antibody; Multiple myeloma; Internal medicine; Immunology; Confidence interval; Cumulative incidence; Incidence (geometry); Gastroenterology; Cohort","retraction":null,"screen_n_in":null,"score":{"opus":0.0270653576593723,"gpt":0.2764829583594968,"spread":0.2494176007001245,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008110263,0.000265934,0.0004957226,0.0005120155,0.0001228668,0.00005863459,0.0000648717,0.00008289293,0.00001823102],"category_scores_gemma":[0.0001443225,0.0001868511,0.00007799949,0.001609034,0.0001714475,0.0005514183,0.00004216682,0.0001887869,0.000008547866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002150977,"about_ca_system_score_gemma":0.0002495296,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005815551,"about_ca_topic_score_gemma":0.005707067,"domain_scores_codex":[0.9981642,0.00008040921,0.0003098487,0.0004398945,0.0005147828,0.0004908161],"domain_scores_gemma":[0.9990049,0.0001161021,0.0001741508,0.0003280094,0.000249987,0.0001268788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001089508,0.002096078,0.9876271,0.00008258561,0.0009415888,0.0001833467,0.0001747579,0.0003338761,0.006028975,0.000003935961,0.0001474037,0.001290772],"study_design_scores_gemma":[0.01519317,0.001387864,0.9648131,0.000805215,0.000279046,0.00001868241,0.0001364709,0.000144326,0.01699354,0.000002205523,0.00003190355,0.0001945336],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980534,0.0001071204,0.000002515852,0.00007416754,0.00007669328,0.001021936,0.0003925502,0.0001379832,0.0001335874],"genre_scores_gemma":[0.9971852,0.0005944198,0.0000312548,0.000009182741,0.00004577125,0.0002203454,0.0007192419,0.00005648801,0.001138151],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02281414,"threshold_uncertainty_score":0.8791413,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3200480347","doi":"10.1158/2643-3230.bcd-20-0208","title":"NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity","year":2021,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; Parker Institute for Cancer Immunotherapy; Entertainment Industry Foundation; Cancer Research Institute; Burroughs Wellcome Fund; Stanford Maternal and Child Health Research Institute; American Association for Cancer Research","keywords":"Haematopoiesis; Progenitor cell; Proinflammatory cytokine; Cancer research; CD34; Endothelial stem cell; Stem cell; Bone marrow; Myeloid; Immunology; Biology; In vitro; Cell biology; Inflammation","retraction":null,"screen_n_in":null,"score":{"opus":0.01625178464506925,"gpt":0.3011283694173624,"spread":0.2848765847722931,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000291902,0.0003874824,0.0007917842,0.0001108761,0.0001367495,0.0002040185,0.0001725712,0.0001750529,0.002394393],"category_scores_gemma":[0.00009131437,0.0003145029,0.0002883484,0.000474054,0.0002838625,0.000395641,0.0001191364,0.0005820015,0.00004247959],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002982209,"about_ca_system_score_gemma":0.001707575,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001528738,"about_ca_topic_score_gemma":0.0003577798,"domain_scores_codex":[0.9970044,0.000233473,0.0003002835,0.0008452015,0.0008964175,0.0007201743],"domain_scores_gemma":[0.998219,0.0003293617,0.0001297841,0.0007128783,0.0003329031,0.0002761023],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.008557337,0.0008173629,0.02257544,0.0002446989,0.0009929335,0.0009392687,0.0002878716,0.000105978,0.962678,0.00001150239,0.000405681,0.002383939],"study_design_scores_gemma":[0.01543075,0.0005501407,0.01878537,0.0002118353,0.0003919329,0.0001165124,0.00006402778,0.00007699644,0.9523959,0.00001564677,0.01159977,0.0003611729],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926218,0.0007967956,0.0002065579,0.000416755,0.0004446402,0.0009068228,0.0006349438,0.000101586,0.003870047],"genre_scores_gemma":[0.9632506,0.000440913,0.0004809038,0.0005854089,0.0007835646,0.0002215332,0.00009433526,0.0001215949,0.03402109],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03015105,"threshold_uncertainty_score":0.9999307,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409872473","doi":"10.1158/2643-3230.bcd-24-0342","title":"Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs; Canada First Research Excellence Fund; Terry Fox Foundation; International Development Research Centre; National Cancer Institute; University of Toronto; Canadian Cancer Society; Government of Ontario; Princess Margaret Cancer Foundation; St. Jude Children's Research Hospital; American Lebanese Syrian Associated Charities; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Atlas (anatomy); Haematopoiesis; Biology; Hierarchy; Genetics; Computational biology; Evolutionary biology; Stem cell; Political science","retraction":null,"screen_n_in":null,"score":{"opus":0.02081339611851763,"gpt":0.2909054888823361,"spread":0.2700920927638185,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001118292,0.0001625251,0.0004921213,0.0002510083,0.0000569544,0.00001802741,0.0001140703,0.00009574847,0.00006597596],"category_scores_gemma":[0.00002623045,0.0001434657,0.000127732,0.0002410611,0.0002034218,0.00009777752,0.00003922527,0.0001326241,5.135764e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001119655,"about_ca_system_score_gemma":0.0004535766,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003980795,"about_ca_topic_score_gemma":0.0001591785,"domain_scores_codex":[0.9985492,0.00006556445,0.0004865175,0.0002927103,0.0003734965,0.0002325269],"domain_scores_gemma":[0.9992691,0.00009304825,0.0001606974,0.0002873698,0.0001209882,0.00006883287],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002850948,0.0005423703,0.1859526,0.002526753,0.00012545,0.00001018122,0.0001711521,0.000009397354,0.8091353,0.00008101674,0.0002500261,0.0009106052],"study_design_scores_gemma":[0.004065325,0.0003200916,0.3651454,0.0009149819,0.000473853,0.000004626861,0.00004772086,0.0001766795,0.6284657,0.0002431918,0.00003737132,0.0001050819],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958196,0.002676906,0.0003245041,0.0002516795,0.00006300219,0.0004319092,0.0001326395,0.00001207443,0.0002877208],"genre_scores_gemma":[0.9975141,0.0002200779,0.0003969435,0.0001157795,0.00004490485,0.0000663661,0.0000319515,0.00001999738,0.001589921],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1806696,"threshold_uncertainty_score":0.5850362,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3108186512","doi":"10.1158/2643-3230.bcd-20-0155","title":"Sphingosine-1-Phosphate Receptor 3 Potentiates Inflammatory Programs in Normal and Leukemia Stem Cells to Promote Differentiation","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":62,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Amgen (Canada); University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; National Institute of General Medical Sciences; Medical Research Council; Canadian Institutes of Health Research; Canadian Cancer Society; Wellcome Trust","keywords":"Haematopoiesis; Myeloid leukemia; Myelopoiesis; Myeloid; Stem cell; Biology; Immunology; Cancer research; Leukemia; Regulator; Hematopoietic stem cell; Cell biology; Inflammation; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.0126590363725166,"gpt":0.2071703709343803,"spread":0.1945113345618636,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001311112,0.0002877284,0.0003659986,0.00007475408,0.00009871056,0.00009773033,0.0002503439,0.0002104872,0.0001448323],"category_scores_gemma":[0.000009576311,0.0002750841,0.0000736776,0.0002417836,0.0001001987,0.0004400736,0.0002503045,0.0003439887,0.0001174356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001504026,"about_ca_system_score_gemma":0.0002001869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003309001,"about_ca_topic_score_gemma":0.0001379874,"domain_scores_codex":[0.9983439,0.00009238495,0.0004515244,0.0005361408,0.0000763253,0.0004996513],"domain_scores_gemma":[0.9994644,0.00002336112,0.0001784946,0.0002312354,0.00004514716,0.00005735063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005458056,0.0001192341,0.04759792,0.0003059424,0.0002631989,0.00001169928,0.002813788,0.0001985365,0.9227898,0.00004424618,0.001413963,0.02389589],"study_design_scores_gemma":[0.002760287,0.0002913082,0.01405123,0.0003257322,0.000117332,0.000005841234,0.0002863446,0.00002245453,0.9665451,0.00001093415,0.01511998,0.0004634398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884794,0.008414636,0.00005944523,0.0007188753,0.001187124,0.0009542326,0.0000521364,0.00008749263,0.00004666174],"genre_scores_gemma":[0.9968764,0.0007429945,0.00007501193,0.0005547364,0.0001222443,0.0003047052,0.00006194737,0.0000461791,0.001215753],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04375535,"threshold_uncertainty_score":0.9999701,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4281960949","doi":"10.1158/2643-3230.bcd-21-0205","title":"Perspectives on the Risk-Stratified Treatment of Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cancer Research UK","keywords":"Multiple myeloma; Risk stratification; Stratification (seeds); Medicine; Oncology; Intensive care medicine; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.03138852994115597,"gpt":0.3023293460820964,"spread":0.2709408161409404,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009336937,0.000168219,0.0002648861,0.00007729669,0.0002916797,0.00002155942,0.0001092488,0.00001802303,0.000675603],"category_scores_gemma":[0.00006580028,0.00009874236,0.0002057326,0.0001951823,0.0001015396,0.00005985503,0.0000493024,0.000146961,0.000008067416],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002934902,"about_ca_system_score_gemma":0.0002926361,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002706331,"about_ca_topic_score_gemma":0.0002799091,"domain_scores_codex":[0.998594,0.0001565585,0.0001720873,0.0003162908,0.0004979481,0.0002631078],"domain_scores_gemma":[0.9990251,0.0002749772,0.000113461,0.000460932,0.00004104129,0.00008446669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00866562,0.01485155,0.8981817,0.00007856623,0.005576941,0.0004326605,0.009771618,0.0008773836,0.02263666,0.003386903,0.00119321,0.03434719],"study_design_scores_gemma":[0.03659428,0.01440128,0.7295085,0.0001117437,0.001535377,0.00007160208,0.02753326,0.0008481672,0.1829259,0.0003055307,0.005700795,0.0004634782],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918018,0.002994549,0.000004433633,0.001109516,0.00008198945,0.0008722782,0.0007386371,0.00002396981,0.002372856],"genre_scores_gemma":[0.9949984,0.001101207,0.00004770668,0.00005694699,0.0001307813,0.0009922135,0.00003672683,0.00002205139,0.002613999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1686732,"threshold_uncertainty_score":0.7397379,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387114589","doi":"10.1158/2643-3230.bcd-23-0062","title":"Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Baker Hughes (Canada); Institute of Cancer Research","funders":"National Cancer Institute","keywords":"Downregulation and upregulation; Cancer research; Enhancer; IRF4; In vivo; Transcription factor; Biology; Chemistry; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.04422116726956159,"gpt":0.3335979144618268,"spread":0.2893767471922652,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001928051,0.0002274243,0.0003484201,0.0003024166,0.000169662,0.00007474018,0.0001268124,0.00005782293,0.0001544478],"category_scores_gemma":[0.00009044002,0.0002015722,0.0001948026,0.0006783214,0.00009814616,0.0004907589,0.00006874639,0.0002403148,0.00008516451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002159583,"about_ca_system_score_gemma":0.0002714937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001951132,"about_ca_topic_score_gemma":0.005963243,"domain_scores_codex":[0.9979458,0.00007714341,0.0003243271,0.0004754793,0.0005770605,0.000600126],"domain_scores_gemma":[0.9992164,0.0001780098,0.00004575715,0.0003038592,0.00006595012,0.0001900032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003146406,0.001188508,0.9527699,0.000186656,0.0003456812,0.000279665,0.0004930739,0.000202785,0.03834287,0.0003174558,0.000387396,0.005171367],"study_design_scores_gemma":[0.01291086,0.00009022892,0.9567478,0.0002580183,0.0001065468,0.0000174296,0.0002597173,0.001522422,0.02712434,0.0001504003,0.0005887441,0.000223481],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953435,0.001273981,0.00002505513,0.001422432,0.0002388197,0.0006334041,0.0004054116,0.0001317008,0.0005256791],"genre_scores_gemma":[0.9952889,0.0007325292,0.0000983471,0.0001314838,0.0001622667,0.0005945229,0.0003802158,0.00004097361,0.002570772],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01259622,"threshold_uncertainty_score":0.8219876,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220858033","doi":"10.1158/2643-3230.bcd-21-0092","title":"Reconstructing Complex Cancer Evolutionary Histories from Multiple Bulk DNA Samples Using Pairtree","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Vector Institute; Artificial Intelligence in Medicine (Canada); University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health","keywords":"clone (Java method); Cancer; Genome; Phylogenetics; Disease; Complex disease","retraction":null,"screen_n_in":null,"score":{"opus":0.03286776492797187,"gpt":0.2526574427517208,"spread":0.2197896778237489,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007209792,0.0002253237,0.0002368538,0.00004622645,0.0004997818,0.00005588144,0.0002675833,0.00006892408,0.0002837554],"category_scores_gemma":[0.00006281329,0.0002659961,0.0001456003,0.0001176939,0.0001206339,0.00001615954,0.0004660081,0.0001437493,7.1485e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003162891,"about_ca_system_score_gemma":0.000710923,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01559162,"about_ca_topic_score_gemma":0.004363949,"domain_scores_codex":[0.9985368,0.00006002848,0.0002884759,0.0005593129,0.0002152349,0.0003401981],"domain_scores_gemma":[0.9992037,0.0000696258,0.0002010104,0.0003846134,0.00006134331,0.00007975419],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002432264,0.0001390634,0.3441224,0.00002930509,0.0003737426,0.00001037304,0.0001754567,0.01430981,0.6297942,0.0001094659,0.008638487,0.002054489],"study_design_scores_gemma":[0.006642632,0.0005502581,0.07346857,0.0001350205,0.001008973,0.0001027664,0.003199075,0.005129599,0.1538883,0.001255823,0.7519916,0.002627421],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9730848,0.0179679,0.0002821115,0.0002087434,0.001596936,0.0001875713,0.006517626,0.0000208413,0.0001334638],"genre_scores_gemma":[0.9940218,0.001114625,0.00164758,0.0005547851,0.001350865,0.0002256658,0.0007937562,0.00005240927,0.0002385566],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7433531,"threshold_uncertainty_score":0.9999792,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3009636168","doi":"10.1158/0008-5472.bcd-19-0039","title":"Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating Functions","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; National Institutes of Health; Cancer Research Society; National Natural Science Foundation of China; American Cyronics Society; U.S. Department of Defense","keywords":"Progenitor cell; Cancer research; Protein phosphatase 2; Biology; Stem cell; Immune system; Immunology; Leukemia; Apoptosis; Cell biology; Phosphatase; Phosphorylation","retraction":null,"screen_n_in":null,"score":{"opus":0.01585045797614332,"gpt":0.2071715928590338,"spread":0.1913211348828905,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008474252,0.0002012346,0.0003082204,0.00007961464,0.0001785541,0.0000320108,0.00008511357,0.0001028031,0.00006294644],"category_scores_gemma":[0.00001754482,0.0001854489,0.00006625958,0.0001543571,0.0001093275,0.0003797891,0.00008528562,0.0003684027,0.0000103427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000678327,"about_ca_system_score_gemma":0.00009166687,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006271534,"about_ca_topic_score_gemma":0.0000978453,"domain_scores_codex":[0.9988434,0.0001947571,0.0003456216,0.0003433558,0.000052925,0.0002199563],"domain_scores_gemma":[0.9993977,0.0001289825,0.0002307854,0.0001487199,0.00006445723,0.00002938665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001528649,0.0003322152,0.0194935,0.0001536856,0.0001238696,0.000001362809,0.003105534,0.00005794024,0.9735907,0.00001044467,0.0007017238,0.0009003195],"study_design_scores_gemma":[0.003869903,0.0007996827,0.02006562,0.0002136558,0.0000946061,0.000002959621,0.00771739,0.00003434422,0.9656547,0.000002167617,0.001291096,0.000253845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957305,0.002609786,0.00001574537,0.00009671699,0.0006117243,0.0002880314,0.0001138902,0.00002080587,0.0005127537],"genre_scores_gemma":[0.9978356,0.0005793255,0.000005408554,0.0002817642,0.0000181108,0.00002995559,0.00004599723,0.00001630876,0.001187563],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007936031,"threshold_uncertainty_score":0.7562388,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388451947","doi":"10.1158/2643-3230.bcd-23-0061","title":"ETV4-Dependent Transcriptional Plasticity Maintains <i>MYC</i> Expression and Results in IMiD Resistance in Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Paula and Rodger Riney Foundation; American Society of Hematology; Multiple Myeloma Research Foundation","keywords":"Transcription factor; Enhancer; Chromatin immunoprecipitation; Chromatin; Biology; Cancer research; Genetics; Promoter; Gene expression; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02987792591273875,"gpt":0.2922991076502167,"spread":0.2624211817374779,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002759975,0.000217993,0.0003421206,0.0003136238,0.0000818507,0.00004795849,0.00009797024,0.00009079774,0.00002497481],"category_scores_gemma":[0.0002283499,0.0001876272,0.00006507147,0.0004491828,0.00009678445,0.0002991072,0.00007738562,0.0003036951,0.00001396717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002197985,"about_ca_system_score_gemma":0.000248325,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00142928,"about_ca_topic_score_gemma":0.02546634,"domain_scores_codex":[0.9977257,0.0000949977,0.0004509054,0.0005882971,0.0005676212,0.000572457],"domain_scores_gemma":[0.9992239,0.000253361,0.00006817845,0.0002226972,0.00003461154,0.0001972376],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01491731,0.001208819,0.7430761,0.0004600772,0.0001377303,0.002719237,0.001150269,0.0004416995,0.2330305,0.0002804645,0.0008277077,0.001749981],"study_design_scores_gemma":[0.02676295,0.0001375337,0.9475335,0.0009870176,0.00003942362,0.0000135332,0.0002494393,0.0004040078,0.0229384,0.0002285931,0.0005034097,0.0002021267],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954244,0.001141155,0.00002560439,0.001028917,0.00009648172,0.0006484086,0.000808925,0.00005789049,0.0007681812],"genre_scores_gemma":[0.995895,0.001444315,0.0002347372,0.000101487,0.0001102175,0.0003312632,0.0001667242,0.00002893751,0.001687362],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2100921,"threshold_uncertainty_score":0.9923164,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404970989","doi":"10.1158/2643-3230.bcd-23-0258","title":"CD33–CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells","year":2024,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Hyundai Hope On Wheels; Saban Research Institute; CureSearch for Children's Cancer; National Cancer Institute; St. Baldrick's Foundation; University of Southern California","keywords":"Interleukin-3 receptor; Cancer research; Haematopoiesis; CD33; Immunotherapy; Progenitor cell; Cytokine release syndrome; Leukemia; T cell; Stem cell; Immunology; Medicine; Biology; CD34; Myeloid; Chimeric antigen receptor; Cell biology; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.02216345704150889,"gpt":0.2911391256570107,"spread":0.2689756686155018,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008936013,0.0002515096,0.0004576237,0.0001082728,0.0001687781,0.0001734626,0.0002040189,0.00009905906,0.0009253649],"category_scores_gemma":[0.00008964794,0.0001789337,0.0001751703,0.0004117901,0.0002470995,0.000278067,0.0001855809,0.000529845,0.000008391725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001335638,"about_ca_system_score_gemma":0.0004391604,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001238381,"about_ca_topic_score_gemma":0.0002224535,"domain_scores_codex":[0.9977666,0.0001277632,0.0004738519,0.0005429182,0.0006127203,0.0004761629],"domain_scores_gemma":[0.9987786,0.0004733993,0.0001200772,0.0004052965,0.0001042674,0.0001183482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001712153,0.00009008976,0.0005537367,0.0006703361,0.0003235851,0.00002964541,0.003757163,0.00007695656,0.9818611,0.00005807125,0.001051838,0.01135624],"study_design_scores_gemma":[0.0005469903,0.0001704023,0.0008025152,0.0008405838,0.0002746989,0.00001455339,0.003244321,0.0003314419,0.9917364,0.0001179463,0.001719373,0.000200784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9764208,0.01589705,0.0000624549,0.0007025814,0.0005690511,0.000578863,0.00007190405,0.00007433481,0.005622918],"genre_scores_gemma":[0.9909905,0.001839616,0.0001662635,0.0001415798,0.001372911,0.00005230559,0.00001032461,0.00006683204,0.005359719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01456961,"threshold_uncertainty_score":0.9999879,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4319827008","doi":"10.1158/2643-3230.bcd-22-0086","title":"<i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Amgen (Canada); Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; McMaster University; University of Toronto; University Health Network","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Stem cell; RNA-binding protein; In vivo; RNA; Cell biology; Computational biology; Biology; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02521687011719345,"gpt":0.2930405608347814,"spread":0.2678236907175879,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005880465,0.0003284316,0.0005778556,0.0006490183,0.0001176692,0.0001862252,0.0002567309,0.0001777171,0.0001121951],"category_scores_gemma":[0.00004529179,0.0003010762,0.0001094615,0.001137422,0.0001670078,0.0008748005,0.0002719285,0.000676813,0.00005448583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000564692,"about_ca_system_score_gemma":0.001080491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003267882,"about_ca_topic_score_gemma":0.000975518,"domain_scores_codex":[0.9971128,0.000144573,0.0004663318,0.0006949364,0.0007106622,0.0008706969],"domain_scores_gemma":[0.9990905,0.0001986161,0.0001220556,0.0003729423,0.00006134302,0.0001545683],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004099729,0.00008350779,0.02628537,0.0005688941,0.0002114613,0.001267306,0.001991612,0.0001769992,0.9671106,0.000108945,0.0008952973,0.0008900653],"study_design_scores_gemma":[0.005264079,0.0002315886,0.004412975,0.001631445,0.0001208616,0.00008125696,0.007233417,0.0005057006,0.9790651,0.0004450028,0.000569815,0.0004387314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934937,0.003048227,0.00002790161,0.001250552,0.0001483062,0.00137579,0.00009010523,0.00008646897,0.0004789538],"genre_scores_gemma":[0.970374,0.00212647,0.0001074944,0.0004121468,0.0001754304,0.0005866999,0.0000114563,0.00008131071,0.02612497],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02564602,"threshold_uncertainty_score":0.9999442,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220999992","doi":"10.1158/2643-3230.bcd-22-0013","title":"Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Hope Foundation; American Cancer Society","keywords":"Malignancy; Risk factor; Population; Cancer; Disease; Risk assessment","retraction":null,"screen_n_in":null,"score":{"opus":0.03486765714881442,"gpt":0.3310159339861123,"spread":0.2961482768372979,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003247856,0.0002384493,0.0005415926,0.0001849727,0.0003251229,0.00002177803,0.000161629,0.00007817092,0.0003979508],"category_scores_gemma":[0.0008047423,0.0002177391,0.0002420369,0.0004214931,0.00006839556,0.000172713,0.0001142628,0.0001784487,0.000001439466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009976375,"about_ca_system_score_gemma":0.003696224,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0238307,"about_ca_topic_score_gemma":0.001214467,"domain_scores_codex":[0.9979469,0.0001522415,0.0004485713,0.0004331425,0.0005582314,0.0004608915],"domain_scores_gemma":[0.9982659,0.0003497015,0.0003635614,0.0004336388,0.0001742047,0.0004130127],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004260347,0.001092497,0.9727114,0.001368678,0.0003998728,0.00002043508,0.0007023879,0.0002660431,0.001382992,0.00005449884,0.01508711,0.002653732],"study_design_scores_gemma":[0.05236186,0.006867997,0.7207505,0.0005121212,0.00377173,0.00008392794,0.001553437,0.0001240515,0.01555998,0.0005805276,0.1968019,0.00103199],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861517,0.002069298,0.00004831168,0.001998971,0.0003131598,0.001513939,0.007678707,0.00007241646,0.0001534786],"genre_scores_gemma":[0.9888294,0.001025885,0.00006395622,0.007526845,0.0001592733,0.0006200148,0.0005856612,0.0000496353,0.001139359],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2519609,"threshold_uncertainty_score":0.9826697,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3086857979","doi":"10.1158/2643-3230.bcd-20-0076","title":"PRPS-ST: A Protocol-Agnostic Self-training Method for Gene Expression–Based Classification of Blood Cancers","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Gene expression and cancer classification","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; Terry Fox Research Institute","keywords":"Computer science; Gene expression; Gene; Porting; Training set; Artificial intelligence; Machine learning; Computational biology; Data mining; Biology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.03953959371689576,"gpt":0.3265509782736628,"spread":0.2870113845567671,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001827788,0.0002589566,0.0002956295,0.00005534619,0.0001061091,0.00004401628,0.0003293304,0.0001873702,0.00003223446],"category_scores_gemma":[0.0001457744,0.0002416608,0.0001957162,0.0002228215,0.00005179302,0.0000224927,0.00006695325,0.0001008789,7.085391e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003231673,"about_ca_system_score_gemma":0.001172501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003058626,"about_ca_topic_score_gemma":0.0000231866,"domain_scores_codex":[0.9981216,0.0001106523,0.0004583489,0.0007339991,0.0002652665,0.0003102013],"domain_scores_gemma":[0.9987224,0.00004679025,0.0004419914,0.0004485986,0.0001763589,0.0001638287],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004840676,0.0001789704,0.0009247735,0.0003597621,0.0001542824,6.513816e-7,0.0002260317,0.001422814,0.9912022,0.00006064293,0.00335853,0.001627219],"study_design_scores_gemma":[0.003339174,0.0005240223,0.0006901642,0.000125349,0.000286312,0.000001681992,0.0001958006,0.001623717,0.9597775,0.00003575439,0.03309609,0.0003044222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.2746158,0.002886985,0.6345266,0.00527273,0.0008525744,0.0778542,0.002349508,0.0002862303,0.001355496],"genre_scores_gemma":[0.8570201,0.00009157511,0.03774498,0.00119204,0.0008259545,0.1025339,0.0003204151,0.00008541465,0.0001856212],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5967816,"threshold_uncertainty_score":0.9854641,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4252017764","doi":"10.1158/2643-3249.bcd-19-0041","title":"Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Institutes of Health; National Cancer Institute; KWF Kankerbestrijding; China Scholarship Council","keywords":"Somatic evolution in cancer; Biology; Somatic hypermutation; Genetics; Mutation; Leukemia; Deep sequencing; Cancer; Gene; Cancer research; Genome; B cell","retraction":null,"screen_n_in":null,"score":{"opus":0.005172263114851585,"gpt":0.2139116121115461,"spread":0.2087393489966945,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003191029,0.00009990728,0.0001251071,0.00003405374,0.00001856654,0.00001592179,0.00007292708,0.00007094593,0.0000116932],"category_scores_gemma":[0.00003561989,0.0001043739,0.0000430774,0.00008673439,0.00002154829,0.000006290923,0.00007333866,0.00004907346,7.559705e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000307759,"about_ca_system_score_gemma":0.0004312396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001443499,"about_ca_topic_score_gemma":0.0001702579,"domain_scores_codex":[0.9993263,0.00001401767,0.0001825825,0.0002465463,0.0001002847,0.0001302202],"domain_scores_gemma":[0.9997243,0.00002199246,0.00008181774,0.00008382044,0.00002966995,0.00005838794],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003795234,0.00007299013,0.9281144,0.000133144,0.0001113134,0.00001674034,0.0001214034,0.005429067,0.06453252,0.0003150769,0.000554824,0.0002190105],"study_design_scores_gemma":[0.006306299,0.0007241386,0.9592463,0.0000498457,0.0004030339,0.00002248571,0.0001447987,0.001157705,0.03092696,0.0002015952,0.0003723874,0.0004444375],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949896,0.003450913,0.000660148,0.000143275,0.00009784741,0.00009029294,0.000514659,0.0000030663,0.00005015587],"genre_scores_gemma":[0.9969895,0.002095214,0.00005364902,0.0002498281,0.000420337,0.00002525627,0.0001221916,0.00001312974,0.00003084184],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03360556,"threshold_uncertainty_score":0.4256245,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3206893004","doi":"10.1158/2643-3230.bcd-20-0216","title":"Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target","year":2021,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Vector Institute; Ontario Institute for Cancer Research; Amgen (Canada); Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Novo Nordisk Fonden; Canadian Institutes of Health Research; KWF Kankerbestrijding; Novo Nordisk; Canadian Cancer Society; Hospital for Sick Children; Government of Ontario","keywords":"Profiling (computer programming); Translation (biology); Messenger RNA; Central nervous system; Neuroscience; Computational biology; Biology; Computer science; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01996526487059861,"gpt":0.2902066750362585,"spread":0.2702414101656599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001508685,0.0002087179,0.0004629238,0.0001092472,0.0000745079,0.00006990381,0.0001374029,0.0001370325,0.00008706458],"category_scores_gemma":[0.0000489401,0.0001843194,0.0002085254,0.0003642729,0.0001063656,0.0003142402,0.00004818811,0.0002218067,0.00001408515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001073125,"about_ca_system_score_gemma":0.004378048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00109287,"about_ca_topic_score_gemma":0.00007495348,"domain_scores_codex":[0.9978563,0.00009914422,0.0004713926,0.0004256411,0.0006645216,0.0004829777],"domain_scores_gemma":[0.9990082,0.0001164567,0.0001462825,0.0003943992,0.0002011872,0.0001334631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001086409,0.000337793,0.01942959,0.004132525,0.001491572,0.0006492037,0.001445887,0.002121931,0.9619275,0.0008820615,0.0002648605,0.006230645],"study_design_scores_gemma":[0.006407088,0.000153691,0.01018401,0.001169659,0.0008848349,0.0003408338,0.001806475,0.009536072,0.9689328,0.00009940235,0.0002313119,0.0002538344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858183,0.009279807,0.002265367,0.0002970335,0.0004878877,0.0005942591,0.0001446661,0.00007768248,0.001034943],"genre_scores_gemma":[0.9966252,0.0004201281,0.0008888211,0.0001237805,0.0003490626,0.00009760217,0.0001293753,0.00005116619,0.001314888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01080682,"threshold_uncertainty_score":0.7766469,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413976388","doi":"10.1158/2643-3230.bcd-25-0005","title":"Timing Genomic Antigen Loss in Multiple Myeloma Treated with T Cell–Redirecting Immunotherapies","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Occupational Cancer Research Centre; University of Calgary","funders":"National Cancer Institute; National Institutes of Health","keywords":"Chimeric antigen receptor; CAR T-cell therapy; Multiple myeloma; Antigen; Immunology; Immunotherapy; Digital polymerase chain reaction; Medicine; Biology; Oncology; Cancer research; Genetics; Immune system; Polymerase chain reaction; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01903899341181398,"gpt":0.2854513872654947,"spread":0.2664123938536807,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009892373,0.0002438933,0.0003947058,0.0002792755,0.0001312255,0.00007062255,0.0001155207,0.00006220015,0.00005627293],"category_scores_gemma":[0.00002480397,0.0001871312,0.00008491758,0.0004571069,0.00009197955,0.0002068662,0.00005900498,0.0002033278,0.000009535683],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002418603,"about_ca_system_score_gemma":0.0004455335,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00738468,"about_ca_topic_score_gemma":0.002005418,"domain_scores_codex":[0.998539,0.00005110789,0.0002576821,0.0004224199,0.0002272673,0.0005024867],"domain_scores_gemma":[0.999352,0.0001142005,0.00007089815,0.000330667,0.00005201055,0.00008024081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001509366,0.0004621715,0.9082658,0.0001499637,0.0005860979,0.0003888061,0.0002791224,0.0001058251,0.07695552,0.00000713824,0.00002911801,0.01126106],"study_design_scores_gemma":[0.01674651,0.0002189103,0.7788402,0.0008062438,0.0001692134,0.00002088854,0.0003081592,0.0003531063,0.2019458,0.00001007541,0.0003694723,0.0002113514],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889231,0.0074153,0.00004457019,0.0002007063,0.00006561691,0.0006709806,0.00004500998,0.00006606491,0.002568664],"genre_scores_gemma":[0.9942748,0.001158317,0.0003922099,0.0001184253,0.00007741919,0.0002147841,0.00004150523,0.0000394682,0.003683059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1294256,"threshold_uncertainty_score":0.9992253,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4410595562","doi":"10.1158/2643-3230.bcd-25-0099","title":"B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Optech (Canada)","funders":"H2020 Marie Skłodowska-Curie Actions; Fondazione Beretta; Fondazione Cariplo; American Society of Hematology; Fondazione AIRC per la ricerca sul cancro ETS","keywords":"Gene silencing; B cell; Cancer research; Biology; Cell; Genetics; Gene; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.01386809793508148,"gpt":0.2705367684569447,"spread":0.2566686705218633,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003508456,0.0002414794,0.000455354,0.0001202627,0.0001312481,0.00008307653,0.0001715198,0.00008798247,0.0001612288],"category_scores_gemma":[0.00002014077,0.0001574212,0.00006348325,0.0004016536,0.0003475352,0.0001987917,0.0001443023,0.0002284976,0.000001825785],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009753291,"about_ca_system_score_gemma":0.0004579517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00228419,"about_ca_topic_score_gemma":0.0002851885,"domain_scores_codex":[0.9982505,0.00009296238,0.000300228,0.0004528747,0.0005315245,0.0003719245],"domain_scores_gemma":[0.9989873,0.0001927194,0.0001296475,0.0004914496,0.00009626776,0.0001026161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000999358,0.0004051135,0.0791975,0.001159767,0.0003749469,0.00002000272,0.0006228108,0.000007568217,0.9076926,0.0002288611,0.006892122,0.002399342],"study_design_scores_gemma":[0.011914,0.0006313627,0.007419755,0.00112375,0.0008306054,0.00003136257,0.001534501,0.0000084954,0.9633613,0.0002340227,0.01261493,0.0002958892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9735877,0.01833027,0.00002207574,0.001190501,0.0001388425,0.0007900051,0.00007414904,0.00002627673,0.005840183],"genre_scores_gemma":[0.9560406,0.01156365,0.0002329401,0.0007211455,0.000120392,0.0001240345,0.00001041157,0.0000358763,0.03115091],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07177775,"threshold_uncertainty_score":0.6419449,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407345273","doi":"10.1158/2643-3230.bcd-24-0140","title":"SOCS1 Protects Acute Myeloid Leukemia against Allogeneic T Cell–Mediated Cytotoxicity","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University of Calgary; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"Suppressor of cytokine signaling 1; Myeloid leukemia; Cancer research; CD8; Leukemia; Immunotherapy; Cytotoxic T cell; Immunology; Medicine; Biology; Cancer; Immune system; Internal medicine; In vitro; Suppressor","retraction":null,"screen_n_in":null,"score":{"opus":0.01176906278345112,"gpt":0.2694262694282391,"spread":0.257657206644788,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009740706,0.0002799283,0.0004204547,0.0001914548,0.0001747184,0.0000843159,0.0001626894,0.0001572927,0.0001537491],"category_scores_gemma":[0.000077766,0.0002440683,0.0002569268,0.0004641516,0.00007973381,0.0002392247,0.00009796685,0.0004451018,0.00004147647],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003960553,"about_ca_system_score_gemma":0.001661492,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004008747,"about_ca_topic_score_gemma":0.0001385285,"domain_scores_codex":[0.9984632,0.0000394031,0.000331112,0.0004821716,0.0002702183,0.0004138599],"domain_scores_gemma":[0.9990917,0.00008105733,0.0001388193,0.0004416737,0.0001155482,0.0001311337],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002373019,0.0002960098,0.00269113,0.0002119923,0.0005887009,0.0000801303,0.0000787223,0.0001509231,0.9869745,0.00006008915,0.007663116,0.00096743],"study_design_scores_gemma":[0.002684867,0.0002094805,0.004531342,0.0005733836,0.0006218176,0.00001525048,0.00007227722,0.0001801227,0.9735071,0.00003774438,0.01730497,0.0002616163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836145,0.001526938,0.0004521604,0.001185247,0.0005887178,0.0008802237,0.0002708464,0.0001689793,0.01131236],"genre_scores_gemma":[0.9868306,0.001263346,0.0001346573,0.003283924,0.0003797621,0.0004335122,0.0001389893,0.00003881723,0.007496383],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01346732,"threshold_uncertainty_score":0.9952819,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4410816810","doi":"10.1158/2643-3230.bcd-25-0049","title":"Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Heart, Lung, and Blood Institute; Division of Cancer Prevention, National Cancer Institute","keywords":"Lymphoblastic Leukemia; Genomics; Biology; Medicine; Leukemia; Genetics; Oncology; Gene; Genome","retraction":null,"screen_n_in":null,"score":{"opus":0.01471057760145185,"gpt":0.3150397892164973,"spread":0.3003292116150455,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001151306,0.000290373,0.0007205025,0.0003224116,0.00003647115,0.00003886589,0.0001942433,0.0001540445,0.00002898892],"category_scores_gemma":[0.00007643695,0.0002274054,0.0001698259,0.0004206061,0.0001904941,0.0001199457,0.0001554464,0.0002413084,0.000004656663],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002262967,"about_ca_system_score_gemma":0.00547289,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002200596,"about_ca_topic_score_gemma":0.0001572766,"domain_scores_codex":[0.9981871,0.00005101796,0.0004488653,0.0004685278,0.0003701054,0.0004744089],"domain_scores_gemma":[0.9989066,0.0003229996,0.0001160485,0.0004574577,0.00006181763,0.0001350901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001250419,0.0004775431,0.9704599,0.0003971868,0.0008200426,0.0001859298,0.0001060938,0.001642778,0.02277232,0.00006121732,0.0004132178,0.001413326],"study_design_scores_gemma":[0.01178807,0.0007194403,0.9764373,0.0004091666,0.0005209805,0.00002174984,0.00006466527,0.001066884,0.008626717,0.0001018977,0.00003109252,0.0002119978],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958207,0.001296151,0.0001299023,0.000137237,0.0002072441,0.0004132832,0.0001728445,0.0000194046,0.001803261],"genre_scores_gemma":[0.9955251,0.00191482,0.0001642834,0.0001784125,0.00007312837,0.00005909623,0.00001154181,0.00003473469,0.002038881],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0141456,"threshold_uncertainty_score":0.9708672,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415596352","doi":"10.1158/2643-3230.bcd-25-0130","title":"CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; Conquer Cancer Foundation; Marcus Foundation; Tanoto Foundation; Johns Hopkins University; Paula and Rodger Riney Foundation; Multiple Myeloma Research Foundation; American Society of Clinical Oncology; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Leukemia and Lymphoma Society; National Institutes of Health","keywords":"Multiple myeloma; Downregulation and upregulation; Cytotoxicity; Cell culture; Tumor cells","retraction":null,"screen_n_in":null,"score":{"opus":0.01260320883669987,"gpt":0.2701118362164872,"spread":0.2575086273797873,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002560073,0.0002758178,0.0004821167,0.0002376199,0.0001241612,0.00009082357,0.00009793295,0.0001170275,0.00002322757],"category_scores_gemma":[0.00009330242,0.0002380817,0.00009918234,0.0003278208,0.00008312373,0.0005127991,0.0001423507,0.0002894152,0.000004520316],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002368598,"about_ca_system_score_gemma":0.0003026665,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01900948,"about_ca_topic_score_gemma":0.002985755,"domain_scores_codex":[0.9979973,0.0001171761,0.0003779016,0.0005883963,0.000385706,0.0005335539],"domain_scores_gemma":[0.9990739,0.0002269839,0.0001086643,0.0003507129,0.00007860079,0.0001611889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001556893,0.0006563701,0.8487105,0.0005581473,0.0007063531,0.0001409604,0.0003096135,0.003889566,0.1175455,0.0005312779,0.0001352473,0.02525958],"study_design_scores_gemma":[0.02832007,0.0003137414,0.8483434,0.0006103837,0.0005222128,0.000003226389,0.0003066928,0.03943871,0.08001441,0.001518238,0.0001651749,0.0004437294],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941562,0.002915794,0.0004635893,0.0002169363,0.0003868405,0.0008927553,0.0003525023,0.00004805755,0.0005673454],"genre_scores_gemma":[0.9958402,0.001528184,0.0005608578,0.00007502122,0.0001940437,0.0001880496,0.0001057865,0.00003187784,0.001475961],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0375311,"threshold_uncertainty_score":0.987523,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4410192422","doi":"10.1158/2643-3230.bcd-24-0240","title":"DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"NHLBI Division of Intramural Research; National Cancer Institute; Canadian Institutes of Health Research; Pharmacyclics; EUSA Pharma; National Institute of Allergy and Infectious Diseases; MorphoSys; Terry Fox Research Institute; Michael Smith Health Research BC; Ministerio de Ciencia e Innovación; Canada's Michael Smith Genome Sciences Centre; Fundación Cellex; St. Jude Children's Research Hospital; Gilead Sciences; TG Therapeutics; Pfizer; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; Amgen; Incyte; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"DNA methylation; Lymphoma; DNA; Burkitt's lymphoma; Methylation; Cancer research; Computational biology; Biology; Medicine; Genetics; Immunology; Gene; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.009172808857633568,"gpt":0.3035139083737359,"spread":0.2943410995161023,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008235104,0.000132174,0.0003487129,0.00005597655,0.00003301354,0.00002316769,0.00003956512,0.00006931493,0.000008455368],"category_scores_gemma":[0.0000416377,0.000088204,0.00009313864,0.0001467393,0.0001167888,0.00007856635,0.00003735603,0.00003803485,4.487238e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004858267,"about_ca_system_score_gemma":0.0002834638,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005737898,"about_ca_topic_score_gemma":0.0002250239,"domain_scores_codex":[0.9991872,0.00003786492,0.0002251933,0.0002665012,0.0001612029,0.000121979],"domain_scores_gemma":[0.999459,0.0001157083,0.00009158246,0.0002240171,0.0000532352,0.0000564413],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007033987,0.001300439,0.9233827,0.0002325871,0.001662911,0.0000952035,0.00004339679,0.000005258886,0.00162056,0.002447918,0.0005180342,0.06798762],"study_design_scores_gemma":[0.005215677,0.0004133847,0.8888389,0.0003943469,0.001725026,0.0000114811,0.00002830687,0.000004220371,0.1024276,0.0001821332,0.0006747892,0.00008408402],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893723,0.007091542,0.0000717751,0.001156842,0.0000945373,0.0002682077,0.00004132851,0.00001696905,0.001886515],"genre_scores_gemma":[0.997862,0.0008903694,0.0001766624,0.0004283114,0.0000519559,0.00005317335,0.00002353406,0.00001007421,0.0005039116],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1008071,"threshold_uncertainty_score":0.3596855,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4248313354","doi":"10.1158/2643-3249.bcd-19-0039","title":"Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating Functions","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Institutes of Health; Cancer Research Society; National Natural Science Foundation of China; American Cyronics Society; U.S. Department of Defense","keywords":"Progenitor cell; Protein phosphatase 2; Cancer research; Biology; Immune system; Stem cell; Immunology; Leukemia; Apoptosis; Cell biology; Phosphatase; Phosphorylation","retraction":null,"screen_n_in":null,"score":{"opus":0.01585045797614332,"gpt":0.2071715928590338,"spread":0.1913211348828905,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008474252,0.0002012346,0.0003082204,0.00007961464,0.0001785541,0.0000320108,0.00008511357,0.0001028031,0.00006294644],"category_scores_gemma":[0.00001754482,0.0001854489,0.00006625958,0.0001543571,0.0001093275,0.0003797891,0.00008528562,0.0003684027,0.0000103427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000678327,"about_ca_system_score_gemma":0.00009166687,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006271534,"about_ca_topic_score_gemma":0.0000978453,"domain_scores_codex":[0.9988434,0.0001947571,0.0003456216,0.0003433558,0.000052925,0.0002199563],"domain_scores_gemma":[0.9993977,0.0001289825,0.0002307854,0.0001487199,0.00006445723,0.00002938665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001528649,0.0003322152,0.0194935,0.0001536856,0.0001238696,0.000001362809,0.003105534,0.00005794024,0.9735907,0.00001044467,0.0007017238,0.0009003195],"study_design_scores_gemma":[0.003869903,0.0007996827,0.02006562,0.0002136558,0.0000946061,0.000002959621,0.00771739,0.00003434422,0.9656547,0.000002167617,0.001291096,0.000253845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957305,0.002609786,0.00001574537,0.00009671699,0.0006117243,0.0002880314,0.0001138902,0.00002080587,0.0005127537],"genre_scores_gemma":[0.9978356,0.0005793255,0.000005408554,0.0002817642,0.0000181108,0.00002995559,0.00004599723,0.00001630876,0.001187563],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007936031,"threshold_uncertainty_score":0.7562388,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4412119851","doi":"10.1158/2643-3230.bcd-24-0327","title":"An Isoform-Specific RUNX1C–BTG2 Axis Governs AML Quiescence and Chemoresistance","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of General Medical Sciences; Leukemia Research Foundation; National Cancer Institute; National Heart, Lung, and Blood Institute; Foundation for the National Institutes of Health; Butler Family Foundation","keywords":"Gene isoform; Cancer research; Biology; Myeloid leukemia; RNA; Transcription factor; Transcription (linguistics); Messenger RNA; Promoter; Chemotherapy; Molecular biology; Gene expression; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.00470263058249781,"gpt":0.2435911064997337,"spread":0.2388884759172359,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008416211,0.0002178185,0.0001860578,0.00004615982,0.0001245116,0.0001096746,0.0002149068,0.0001750253,0.00002074711],"category_scores_gemma":[0.00001289468,0.0002267307,0.00007472682,0.0001977988,0.00014642,0.00003841918,0.00009996531,0.0001007909,0.000002042835],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007229993,"about_ca_system_score_gemma":0.0002236461,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001413347,"about_ca_topic_score_gemma":0.0009360404,"domain_scores_codex":[0.9986764,0.00002833758,0.0002263017,0.0006041836,0.0001646645,0.000300069],"domain_scores_gemma":[0.9991989,0.000008631793,0.0001002787,0.0005558365,0.00006264848,0.00007374033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003743553,0.0001478256,0.01481292,0.0001131544,0.0001829874,0.000002529776,0.00006980383,0.0004950666,0.961007,0.0008491644,0.007393384,0.01455179],"study_design_scores_gemma":[0.001819824,0.0002325494,0.1050674,0.0001940582,0.0001380156,0.000009294941,0.0001574005,0.0001289242,0.8134573,0.0002861469,0.0779539,0.0005551866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9730461,0.02279462,0.001687339,0.0003941839,0.0004320938,0.0002321505,0.0001396365,0.0000265109,0.001247399],"genre_scores_gemma":[0.9870054,0.007741713,0.0001780973,0.0002648001,0.0004044426,0.00007844567,0.0001019136,0.00002642231,0.004198724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1475497,"threshold_uncertainty_score":0.924581,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4417055360","doi":"10.1158/2643-3230.bcd-25-0246","title":"Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"HCA International Foundation; Wellcome Trust; Nationales Centrum für Tumorerkrankungen Heidelberg; Wilhelm Sander-Stiftung; José Carreras Leukämie-Stiftung; Joachim Herz Stiftung; Deutsche Forschungsgemeinschaft; Deutsches Krebsforschungszentrum","keywords":"Juvenile myelomonocytic leukemia; Reprogramming; Fetus; Mutation; Gene; PTPN11; Leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.01672271983316454,"gpt":0.30993910152471,"spread":0.2932163816915455,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004706617,0.0002380105,0.0005244915,0.000397738,0.00005332624,0.00007895102,0.0001484565,0.0001592093,0.000009615036],"category_scores_gemma":[0.0003855674,0.0002183596,0.00007809696,0.0007114952,0.0002354148,0.0001810056,0.0001734983,0.0006812283,0.000002189309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001560338,"about_ca_system_score_gemma":0.002143937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005196757,"about_ca_topic_score_gemma":0.002371463,"domain_scores_codex":[0.9977948,0.000135321,0.0005449528,0.0006723005,0.0003034502,0.0005491581],"domain_scores_gemma":[0.9990546,0.0003456547,0.00006955052,0.0003912098,0.00004833008,0.00009063293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01792379,0.002231816,0.5974953,0.005147379,0.001648215,0.004790444,0.008174757,0.01056893,0.1081007,0.01068532,0.0008951116,0.2323382],"study_design_scores_gemma":[0.07501777,0.002093371,0.6703342,0.007547948,0.001218344,0.0002011131,0.00755328,0.01940781,0.2000541,0.007713479,0.007028118,0.001830504],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899765,0.005198139,0.0001000046,0.001325074,0.0000960699,0.0006866052,0.00003110231,0.00004237784,0.002544109],"genre_scores_gemma":[0.9970039,0.0004357786,0.0002271335,0.0004914486,0.00006183451,0.0002773832,0.0000139698,0.00002724345,0.001461348],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2305077,"threshold_uncertainty_score":0.8904447,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4294771401","doi":"10.1158/2643-3249.lymphoma22-a19","title":"Abstract A19: Integrated single cell analysis reveals co-evolution of malignant B cells and the tumor microenvironment in transformed follicular lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Diffuse large B-cell lymphoma; Follicular lymphoma; Transcriptome; Lymphoma; Somatic evolution in cancer; Tumor microenvironment; Cancer research; Phenotype; Cancer; Genetics; Gene; Immunology; Tumor cells; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.006782715877148441,"gpt":0.2155351354521206,"spread":0.2087524195749721,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000254765,0.0001943327,0.0005639098,0.0001739283,0.00009134941,0.00002236899,0.00008992218,0.0000312964,0.0001811507],"category_scores_gemma":[0.000003989648,0.0001278705,0.0002840167,0.0004537273,0.0001272379,0.00008263525,0.00003745358,0.00006844933,0.00000131492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007825918,"about_ca_system_score_gemma":0.0001912557,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004964243,"about_ca_topic_score_gemma":0.0002932439,"domain_scores_codex":[0.998533,0.00009586278,0.0004398492,0.0003363556,0.0003485948,0.000246405],"domain_scores_gemma":[0.9993659,0.00007970232,0.0001955007,0.0002807688,0.00001383139,0.00006434227],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003242755,0.01134581,0.4286745,0.0004761587,0.004171807,0.0005219913,0.001884029,0.003241513,0.5423043,0.0001599515,0.0006267668,0.003350453],"study_design_scores_gemma":[0.01930256,0.0004403401,0.5616361,0.0001417163,0.004735,0.00002638641,0.001758875,0.0001029232,0.4106449,0.00003957395,0.0009549622,0.0002165994],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881808,0.009864158,0.00001848438,0.0003766462,0.00005213043,0.0007321584,0.00048092,0.000008262414,0.0002864156],"genre_scores_gemma":[0.9976767,0.001328384,0.00003148348,0.00019318,0.00001782943,0.0004567279,0.00008395711,0.00001688369,0.0001948834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1329617,"threshold_uncertainty_score":0.7504483,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3108449195","doi":"10.1158/2643-3249.lymphoma20-po-32","title":"Abstract PO-32: NFKBIZ 3′ UTR mutations confer selective growth advantage and affect drug response in diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Occupational Cancer Research Centre; Spinal Cord Injury BC; Canadian Centre for Applied Research in Cancer Control; Simon Fraser University","funders":"","keywords":"Diffuse large B-cell lymphoma; Untranslated region; Biology; Mutation; Three prime untranslated region; Cancer research; Mutant; Cell growth; Signal transduction; CRISPR; Gene; Genetics; Lymphoma; Messenger RNA; Molecular biology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.009652214431649287,"gpt":0.2629226390862386,"spread":0.2532704246545894,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001343757,0.0002934621,0.0004517309,0.0001130317,0.00008726891,0.00007767499,0.00007265424,0.00008130458,0.0000467969],"category_scores_gemma":[0.0001010306,0.0002472481,0.0001227414,0.0002892498,0.00006492656,0.0003505047,0.00006286354,0.0001153811,0.00002305583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002444202,"about_ca_system_score_gemma":0.0005143364,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006597475,"about_ca_topic_score_gemma":0.0003466511,"domain_scores_codex":[0.9984334,0.0000997542,0.0002791371,0.0005359885,0.0002580053,0.0003937156],"domain_scores_gemma":[0.9990435,0.0003541892,0.0001044509,0.0001931095,0.00005498606,0.0002497538],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01438304,0.03118587,0.9108918,0.0009236128,0.001045232,0.003589409,0.009776615,0.00001154722,0.02141001,0.0005489864,0.004171407,0.002062526],"study_design_scores_gemma":[0.05155366,0.0005973743,0.8627887,0.0002488984,0.0005534737,0.0000312013,0.0009755607,0.00003399788,0.08209245,0.00004487618,0.00076179,0.0003180338],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900686,0.004298634,0.000007808821,0.00309451,0.00007423168,0.0007275051,0.0004725248,0.00005863486,0.001197561],"genre_scores_gemma":[0.9960105,0.001371402,0.00003840189,0.001729704,0.0001247901,0.0003194151,0.00007314401,0.00004506062,0.000287588],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06068244,"threshold_uncertainty_score":0.999998,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3108297018","doi":"10.1158/2643-3249.lymphoma20-po-22","title":"Abstract PO-22: Compromised counterselection by FAS creates a lethal subtype of germinal center lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Germinal center; Fas ligand; Biology; Apoptosis; Cancer research; B cell; Lymphoma; Programmed cell death; Immunology; Genetics; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.01587235240195315,"gpt":0.2583213546670012,"spread":0.2424490022650481,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003449922,0.0002184038,0.0004135234,0.00003751967,0.00004547073,0.00004132948,0.00007625532,0.00008036987,0.0003027071],"category_scores_gemma":[0.00001350201,0.0001784005,0.0001774063,0.0001415736,0.00006926567,0.0001939512,0.00002672676,0.00005900101,0.00001970752],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001587781,"about_ca_system_score_gemma":0.0002772432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001520968,"about_ca_topic_score_gemma":0.00003580217,"domain_scores_codex":[0.9987751,0.00001733874,0.0003008377,0.0003485168,0.0003057089,0.0002525483],"domain_scores_gemma":[0.9993998,0.0000398164,0.0001624093,0.0001686547,0.00007094971,0.0001583369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003700254,0.006107742,0.820985,0.0007606444,0.001803965,0.0003723824,0.0007175927,0.00001267089,0.1230806,0.00005385021,0.0322067,0.01019858],"study_design_scores_gemma":[0.02016121,0.00149645,0.5433286,0.0004684603,0.001068878,0.0001021085,0.0002148105,0.00005519597,0.4264431,0.000009080565,0.006321867,0.0003302217],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933746,0.002302735,0.000008587774,0.00124654,0.0001437696,0.0003514574,0.000395283,0.00004207552,0.002134996],"genre_scores_gemma":[0.997887,0.0004926143,0.00002492957,0.0008507554,0.0002286887,0.000085768,0.0001556754,0.00002856502,0.0002460031],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3033625,"threshold_uncertainty_score":0.7274961,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4367603727","doi":"10.1158/2643-3249.aml23-a54","title":"Abstract A54: Polyamines are required for AML LSC function through their role in regulating eIF5A dependent protein synthesis","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Arginine; Haematopoiesis; Myeloid leukemia; Stem cell; Progenitor cell; Biology; Leukemia; Cancer research; Polyamine; Metabolite; Biochemistry; Myeloid; Cell biology; Immunology; Amino acid","retraction":null,"screen_n_in":null,"score":{"opus":0.01811990868516516,"gpt":0.2624131206114914,"spread":0.2442932119263262,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001370918,0.0001881246,0.0001988397,0.00005270962,0.0001090409,0.00005319097,0.0001749391,0.0001234705,0.000008111712],"category_scores_gemma":[0.00007647478,0.0001694718,0.0001137365,0.0002045572,0.00003985424,0.00003223132,0.00008516668,0.00006038387,0.000005011389],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001582954,"about_ca_system_score_gemma":0.00008798583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003595185,"about_ca_topic_score_gemma":0.0006924477,"domain_scores_codex":[0.9988176,0.00002402187,0.0002636724,0.0004480322,0.0001152841,0.0003314475],"domain_scores_gemma":[0.9993604,0.0000295069,0.000160685,0.0003755555,0.00003671952,0.00003711149],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001125024,0.0001040639,0.002134911,0.00007367789,0.00007471777,7.722181e-7,0.00004943836,0.0001870953,0.9880185,0.0001575253,0.000450469,0.008636324],"study_design_scores_gemma":[0.0007110036,0.00004592751,0.05507877,0.0001161252,0.00006969582,0.000001551552,0.0006288111,0.000057794,0.9353946,0.0009917113,0.00662492,0.000279078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940736,0.003468005,0.0004645335,0.0003852192,0.0001321018,0.0006253176,0.0005237172,0.0000402521,0.0002872954],"genre_scores_gemma":[0.9948194,0.0003663981,0.0001202776,0.00008926792,0.0006233049,0.002320069,0.0001968842,0.00004074015,0.001423665],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05294386,"threshold_uncertainty_score":0.6910859,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4294919189","doi":"10.1158/2643-3230.bcd-22-0120","title":"Q&amp;A: John Dick on Stem Cells and Discoveries","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Stem cell; Environmental ethics; Biology; Philosophy; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02585182521845221,"gpt":0.2791861573553381,"spread":0.2533343321368859,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001436027,0.0001269185,0.0002118599,0.00006654119,0.0002184628,0.00004536087,0.00006173058,0.00006482929,0.0002546468],"category_scores_gemma":[0.00000337912,0.00009711232,0.00006777317,0.0001691659,0.0003009786,0.000109716,0.000133629,0.0003351519,0.00000436609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006892926,"about_ca_system_score_gemma":0.0002060615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001953335,"about_ca_topic_score_gemma":0.00005932842,"domain_scores_codex":[0.998794,0.00004319143,0.0001703119,0.0002885238,0.0005134739,0.0001905471],"domain_scores_gemma":[0.9995377,0.00004719198,0.000070061,0.0002182215,0.00001752699,0.000109313],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00804327,0.008354455,0.05814523,0.004747762,0.003587921,0.0006239567,0.01405543,0.002259592,0.3495355,0.1394512,0.1186923,0.2925034],"study_design_scores_gemma":[0.007551526,0.002143952,0.04084911,0.0005212123,0.000950932,0.000123987,0.001771447,0.0001583569,0.0326364,0.003043667,0.9094569,0.0007925177],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9817096,0.003485802,0.0000849183,0.01191316,0.0007800829,0.0002892822,0.0002591971,0.00004020054,0.001437767],"genre_scores_gemma":[0.9830031,0.00106789,0.00002996683,0.001950737,0.0002771267,0.00008762209,0.00003788946,0.00002296703,0.01352275],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7907646,"threshold_uncertainty_score":0.3960125,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3107639073","doi":"10.1158/2643-3249.lymphoma20-po-62","title":"Abstract PO-62: Overcoming venetoclax resistance in B-cell malignancies by antagonism of stromal TGF-beta-mediated drug resistance","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Stromal cell; Cancer research; Tumor microenvironment; Stroma; Venetoclax; Drug resistance; Biology; Leukemia; Medicine; Immunology; Chemistry; Chronic lymphocytic leukemia; Tumor cells","retraction":null,"screen_n_in":null,"score":{"opus":0.01165107891578242,"gpt":0.245988149186268,"spread":0.2343370702704856,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001683775,0.000462596,0.0009495368,0.0001079915,0.00007462528,0.00004601225,0.0003428822,0.00014072,0.0001070964],"category_scores_gemma":[0.00005744436,0.0004633026,0.0002063193,0.0005762663,0.0002600561,0.0006414815,0.00008921967,0.0004725576,0.00000875135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000415361,"about_ca_system_score_gemma":0.0008555792,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004179842,"about_ca_topic_score_gemma":0.0008791464,"domain_scores_codex":[0.9969253,0.00005966875,0.0008462814,0.0007827615,0.000694793,0.0006911905],"domain_scores_gemma":[0.998444,0.0001653505,0.0005124705,0.0005260691,0.0001102618,0.000241901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00525584,0.0004771952,0.02829124,0.002497676,0.000326543,0.0002900848,0.002483865,0.0001927082,0.9540402,0.0002767108,0.005521632,0.0003463255],"study_design_scores_gemma":[0.01438956,0.0002027899,0.0727047,0.002592096,0.0003973894,0.000007444251,0.001110148,0.0000150426,0.8653067,0.000271827,0.04196929,0.001033062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9431611,0.04930539,0.00009157681,0.003631234,0.0002147221,0.0006275087,0.001199654,0.00009635348,0.001672513],"genre_scores_gemma":[0.9937819,0.001396004,0.0007637158,0.001228954,0.0002947528,0.0001310618,0.0001168767,0.0001037713,0.002182994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08873352,"threshold_uncertainty_score":0.9997818,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3110575363","doi":"10.1158/2643-3249.lymphoma20-po-26","title":"Abstract PO-26: Prognostic significance of Fc gamma receptor IIB expression in the response of previously untreated diffuse large B-cell lymphomas to anti-CD20 monoclonal antibodies: Differing impact of rituximab and obinutuzumab","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Rituximab; International Prognostic Index; CHOP; CD20; Tissue microarray; Immunohistochemistry; Lymphoma; Medicine; Diffuse large B-cell lymphoma; Monoclonal antibody; Cancer research; Internal medicine; Oncology; Antibody; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.02231961598826306,"gpt":0.3019578942477443,"spread":0.2796382782594812,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004210075,0.0003502825,0.0009602915,0.0001764864,0.00006309519,0.00003115898,0.000320921,0.0001151538,0.0000867476],"category_scores_gemma":[0.0003343961,0.0002260035,0.0002634072,0.0005344664,0.0002160052,0.0001982749,0.0001925219,0.0002696005,0.000004023112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000114304,"about_ca_system_score_gemma":0.0007856484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001515113,"about_ca_topic_score_gemma":0.00005525076,"domain_scores_codex":[0.9972785,0.000232711,0.0007555187,0.0004999065,0.0006907112,0.0005426936],"domain_scores_gemma":[0.9982481,0.0006660646,0.0003222787,0.0003710103,0.000146428,0.0002461245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01740258,0.002328642,0.3101683,0.001755614,0.0001697338,0.00007920618,0.003225973,0.0000722163,0.664195,0.000005822054,0.000301339,0.0002955427],"study_design_scores_gemma":[0.01029958,0.002373261,0.6426589,0.001643459,0.0001494089,0.00001428749,0.0005432828,0.0001197426,0.3418474,0.000006167703,0.0001116206,0.0002327662],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927668,0.004269769,0.00001443328,0.0005207814,0.00003592254,0.001285555,0.00101186,0.00002045357,0.00007441227],"genre_scores_gemma":[0.997385,0.00196333,0.0001692227,0.0001113074,0.00009792402,0.00008380163,0.00004055367,0.00004555002,0.0001033447],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3324907,"threshold_uncertainty_score":0.9216155,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4367553368","doi":"10.1158/2643-3249.aml23-ia03","title":"Abstract IA03: Inducing apoptosis in leukemia stem cells by targeting metabolism","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"Myeloid leukemia; Leukemia; Cancer research; Stem cell; Apoptosis; Medicine; Cancer; Population; Disease; Myelodysplastic syndromes; Cancer stem cell; Immunology; Biology; Bone marrow; Internal medicine; Cell biology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02077000338986654,"gpt":0.2875100773813973,"spread":0.2667400739915307,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006881165,0.0003211916,0.0006106759,0.0004049911,0.000106601,0.000119203,0.0002949461,0.0002250587,0.0001671006],"category_scores_gemma":[0.00005610302,0.0002935317,0.000168595,0.001322242,0.00008096056,0.0005627003,0.0002201855,0.0008925161,0.0001862525],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009302651,"about_ca_system_score_gemma":0.001319735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004366888,"about_ca_topic_score_gemma":0.00007941524,"domain_scores_codex":[0.9969752,0.00006888934,0.0005560725,0.0006938918,0.0007306293,0.0009752749],"domain_scores_gemma":[0.9988983,0.0001880868,0.0001439924,0.000465958,0.00006993689,0.0002337641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001888261,0.0001374509,0.01068869,0.0004793868,0.0003084164,0.0001622007,0.0007481221,0.0005789584,0.8867497,0.00003084962,0.09211352,0.007813913],"study_design_scores_gemma":[0.004649781,0.00006115784,0.02210963,0.0005627316,0.0002355293,0.00000687869,0.001647566,0.0003144119,0.9562709,0.00002964215,0.01360814,0.0005036661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928454,0.003452315,0.00001004858,0.0009355454,0.00045015,0.0005481865,0.0001745336,0.0001774811,0.001406303],"genre_scores_gemma":[0.989702,0.003195011,0.00008494769,0.0004940844,0.0005943484,0.0002497532,0.00009611592,0.0001060952,0.005477613],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07850538,"threshold_uncertainty_score":0.9999517,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4294775244","doi":"10.1158/2643-3249.lymphoma22-a24","title":"Abstract A24: <i>BTG1</i> mutations confer a fitness advantage and promote aggressive B cell lymphoma development by lowering the threshold for MYC induction","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Germinal center; Lymphoma; Cancer research; Mutation; B cell; Immunology; Genetics; Gene; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.00733294582110307,"gpt":0.2367027978724541,"spread":0.229369852051351,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009348246,0.0001568194,0.0001087277,0.00002763524,0.0003886685,0.00006272696,0.00012149,0.00006905299,0.00001810945],"category_scores_gemma":[0.000007090649,0.0001414982,0.00005545629,0.0000816376,0.00006324773,0.00002237796,0.0001264952,0.00007628825,3.941699e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008495251,"about_ca_system_score_gemma":0.0003189534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004857027,"about_ca_topic_score_gemma":0.00009438522,"domain_scores_codex":[0.99905,0.0000154809,0.0001965452,0.0003663614,0.0001630559,0.0002085138],"domain_scores_gemma":[0.9994955,0.00001118284,0.0002144426,0.0001946607,0.00004573925,0.00003845401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002521521,0.0002465921,0.0005543957,0.00009588161,0.0002111527,0.000002883681,0.0005543795,0.004430333,0.9769877,0.00001819105,0.002218736,0.01442756],"study_design_scores_gemma":[0.002298773,0.0001486841,0.002007675,0.0000389712,0.0001134858,0.00002879337,0.0005914827,0.00008002676,0.9519942,0.00005885373,0.04233089,0.0003081457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989974,0.00787431,0.0005172706,0.0002200589,0.0003474602,0.0006269253,0.0003045456,0.00001198158,0.0001235117],"genre_scores_gemma":[0.9968296,0.000369609,0.00005913624,0.0001116928,0.0001679339,0.0009844914,0.0005313017,0.00003320209,0.0009129908],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04011216,"threshold_uncertainty_score":0.577013,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3109872911","doi":"10.1158/2643-3249.lymphoma20-po-10","title":"Abstract PO-10: Histone 1 deficiency drives lymphoma through disruption of 3D chromatin architecture","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chromatin; Biology; Missense mutation; Genetics; Mutant; Gene; Histone; Molecular biology; Phenotype","retraction":null,"screen_n_in":null,"score":{"opus":0.01033149410809316,"gpt":0.2566450905430812,"spread":0.2463135964349881,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003442038,0.0001889863,0.0002127276,0.00001817609,0.00005523214,0.00003290547,0.000209483,0.0001060667,0.0000896875],"category_scores_gemma":[0.000062206,0.0001815535,0.0001248613,0.0001030598,0.0001179405,0.00001260267,0.0001170305,0.00005451723,0.000005992975],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002778175,"about_ca_system_score_gemma":0.0002646295,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002371347,"about_ca_topic_score_gemma":0.0001226254,"domain_scores_codex":[0.9989363,0.00001514262,0.0002733305,0.0003899679,0.0001598666,0.0002254122],"domain_scores_gemma":[0.9994066,0.00001847305,0.000182837,0.0002753237,0.00004520992,0.00007153196],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002478144,0.0002990035,0.001348568,0.000248446,0.0001164632,0.000008479617,0.0005653899,0.0026361,0.9800935,0.0002371307,0.003016139,0.01118295],"study_design_scores_gemma":[0.002831655,0.0009166267,0.03002836,0.000128555,0.0002604561,0.00001453733,0.0002363345,0.00004338413,0.931039,0.0003266273,0.03347662,0.0006978555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837416,0.01126672,0.001526179,0.0005150879,0.0001755299,0.0001670702,0.000451363,0.00001252388,0.002143953],"genre_scores_gemma":[0.9956601,0.002336647,0.000535347,0.0006084962,0.0004957412,0.00003432341,0.0001570588,0.00003012419,0.0001422075],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04905453,"threshold_uncertainty_score":0.7403538,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4294771021","doi":"10.1158/2643-3249.lymphoma22-a12","title":"Abstract A12: Pervasive hypermutation of super-enhancer regions dysregulates oncogene expression in diffuse large B-cell lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Simon Fraser University","funders":"","keywords":"Biology; Diffuse large B-cell lymphoma; Somatic hypermutation; Enhancer; Genetics; Gene; Cancer research; Germinal center; B cell; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.012631251303587,"gpt":0.2578647238791112,"spread":0.2452334725755242,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009827584,0.0002213136,0.0004177448,0.0001579794,0.0001372332,0.0000209381,0.0001145998,0.00006575184,0.0003360909],"category_scores_gemma":[0.00001531314,0.0001907504,0.000192901,0.0002780449,0.00004415694,0.0002529522,0.0001250847,0.00008773283,0.000006451843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004760347,"about_ca_system_score_gemma":0.0004654878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008315486,"about_ca_topic_score_gemma":0.0002420039,"domain_scores_codex":[0.9983485,0.00005403984,0.0003936769,0.0004195155,0.0004572307,0.0003269959],"domain_scores_gemma":[0.9992058,0.00009544473,0.0001844416,0.0003690479,0.0000529641,0.00009224888],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001546385,0.07944908,0.3312343,0.0006840273,0.0005088142,0.0008798325,0.004714626,0.0005603964,0.569994,0.0003195925,0.003451652,0.006657308],"study_design_scores_gemma":[0.03632691,0.000452517,0.3373397,0.0004192802,0.0004125886,0.00003980805,0.001919574,0.00003547087,0.6208299,0.0001026695,0.00184632,0.0002752065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884214,0.00911673,0.000005288,0.0004805262,0.0002074457,0.0005128223,0.0004098089,0.0000265694,0.0008193987],"genre_scores_gemma":[0.9960436,0.001727189,0.00006085945,0.0002381717,0.0001013311,0.0008053177,0.0002205792,0.00003806232,0.0007648712],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07899657,"threshold_uncertainty_score":0.7778576,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4392384143","doi":"10.1158/2643-3249.bcdsymp24-p02","title":"Abstract P02: Uncovering Tailored Therapies for Acute Myeloid Leukemia in Children with Down Syndrome","year":2024,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McGill University","funders":"","keywords":"Myeloid leukemia; Medicine; Down syndrome; Myeloid; Intensive care medicine; Immunology; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.01149696719486758,"gpt":0.2869133705003545,"spread":0.2754164033054869,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002440576,0.0003843363,0.0005752861,0.0003485715,0.0000837894,0.0002738059,0.0002657985,0.0001665652,0.0001318179],"category_scores_gemma":[0.00002071667,0.0002834853,0.0001884753,0.0006180363,0.0001495037,0.0007895812,0.00009339004,0.0006164109,0.00002760782],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001541027,"about_ca_system_score_gemma":0.002827801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002199372,"about_ca_topic_score_gemma":0.0004154237,"domain_scores_codex":[0.9975899,0.00002048688,0.0003697532,0.0007434413,0.000529197,0.0007471827],"domain_scores_gemma":[0.9991189,0.000118822,0.0000654231,0.0004784299,0.00005988426,0.000158493],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01192756,0.001110506,0.6025934,0.005825529,0.04476643,0.008068013,0.005125084,0.007606878,0.2244965,0.001874453,0.01951638,0.06708921],"study_design_scores_gemma":[0.01601089,0.001969259,0.9312769,0.004028447,0.002526473,0.002565105,0.0005288528,0.0006846496,0.03325675,0.000618326,0.005158395,0.001375913],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875776,0.008498587,0.000184904,0.0009926568,0.0001873525,0.001530801,0.0003589706,0.0001735004,0.0004956234],"genre_scores_gemma":[0.9928414,0.002421139,0.0004005754,0.000313707,0.0004043382,0.0008408255,0.0001636995,0.0001387181,0.002475635],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3286835,"threshold_uncertainty_score":0.9999617,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3109625190","doi":"10.1158/2643-3249.lymphoma20-po-40","title":"Abstract PO-40: FOXO1 mutations mimic positive selection signals to promote germinal center B-cell expansion and lymphomagenesis","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Germinal center; FOXO1; B cell; Biology; Cancer research; Cancer; PI3K/AKT/mTOR pathway; Lymphoma; Transcription factor; Mutant; Gene; Genetics; Signal transduction; Immunology; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.010457849226038,"gpt":0.2415434336151686,"spread":0.2310855843891306,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003708046,0.0001711849,0.0001251315,0.00004199042,0.00009374355,0.00007525017,0.00006996432,0.00009434084,0.00003334424],"category_scores_gemma":[0.000009454542,0.0001775669,0.00007554091,0.0001224937,0.00003164846,0.0000371781,0.00003130465,0.00004911962,0.000008687375],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002727236,"about_ca_system_score_gemma":0.0001115003,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001021648,"about_ca_topic_score_gemma":0.0000705952,"domain_scores_codex":[0.9990112,0.00003062078,0.0001859873,0.0004354031,0.000145738,0.0001911037],"domain_scores_gemma":[0.9996164,0.000005106736,0.0000719367,0.0001006336,0.00007264115,0.0001333067],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002435689,0.0001257446,0.003143659,0.00005174475,0.00005736791,0.000002847748,0.0002520173,0.0005461508,0.9930842,0.000002133981,0.0004080451,0.00208254],"study_design_scores_gemma":[0.001010502,0.0003177385,0.0883138,0.00003682889,0.0000881161,0.00001002321,0.00006085429,0.00006678155,0.9088537,0.000006947949,0.001015282,0.0002194011],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959964,0.0005506513,0.00193538,0.0006777935,0.0000837151,0.0003567041,0.0002593674,0.00002140109,0.0001185982],"genre_scores_gemma":[0.9981397,0.0001188541,0.0002807865,0.0007181828,0.0002141344,0.00005810513,0.0002413804,0.00002906229,0.0001998357],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08517015,"threshold_uncertainty_score":0.7240968,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3110516422","doi":"10.1158/2643-3249.lymphoma20-po-42","title":"Abstract PO-42: TBL1XR1 mutations drive extranodal lymphomagenesis by inducing a protumorigenic memory B-cell fate","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; University of Toronto","funders":"","keywords":"Germinal center; BCL6; Biology; Transcription factor; Cancer research; Phenotype; Cell fate determination; Lymphoma; Reprogramming; B cell; Immune system; Cell; Gene; Immunology; Genetics; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.02507749552767352,"gpt":0.2904823327413624,"spread":0.2654048372136889,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001733708,0.0003543674,0.0005024279,0.0001218628,0.0001722402,0.0001480366,0.0002742989,0.0001418486,0.003855737],"category_scores_gemma":[0.00005003581,0.0003353553,0.0002917231,0.0005646144,0.0001457154,0.0004476245,0.00008935305,0.0004197669,0.0001487865],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002583301,"about_ca_system_score_gemma":0.001273411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001190632,"about_ca_topic_score_gemma":0.00008117504,"domain_scores_codex":[0.9972727,0.00006890841,0.0004594995,0.0007545928,0.0007818073,0.0006625315],"domain_scores_gemma":[0.9987273,0.00009305886,0.0001517138,0.0004548051,0.0001230282,0.000450149],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006244341,0.000567794,0.004152598,0.000491583,0.0004036749,0.0002605721,0.001925225,0.0001015029,0.975775,0.000004211047,0.003674425,0.01201896],"study_design_scores_gemma":[0.008136281,0.0004818632,0.01265937,0.000213947,0.00057742,0.00004868566,0.001272889,0.0001087132,0.9706259,0.00002616907,0.005302964,0.0005458255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98319,0.00450692,0.0001159107,0.002362166,0.000199751,0.001465271,0.0003025434,0.0001249747,0.007732481],"genre_scores_gemma":[0.9847895,0.0008380734,0.0001269826,0.001254116,0.0007880772,0.0005466266,0.0001184718,0.0001220534,0.01141613],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01147314,"threshold_uncertainty_score":0.9999098,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3109158687","doi":"10.1158/2643-3249.lymphoma20-po-04","title":"Abstract PO-04: Noncoding mutations in mantle cell lymphoma disrupt regulation of HNRNPH1 by alternative splicing","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Simon Fraser University","funders":"","keywords":"Minigene; RNA splicing; Biology; Exonic splicing enhancer; Exon; Intron; Alternative splicing; Genetics; Exon skipping; Splicing factor; Silent mutation; Nonsense-mediated decay; Mutation; Cancer research; Molecular biology; RNA; Gene; Missense mutation","retraction":null,"screen_n_in":null,"score":{"opus":0.01310041543215035,"gpt":0.2738839860172324,"spread":0.260783570585082,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007221126,0.0001125167,0.0001420962,0.00003748181,0.00006377749,0.00002689209,0.0001406203,0.00005979189,0.00001638077],"category_scores_gemma":[0.00003061704,0.0001124025,0.00006425632,0.0001302384,0.00004387096,0.00002663566,0.00009275357,0.00006094923,0.000002449022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002843686,"about_ca_system_score_gemma":0.0001140308,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009465291,"about_ca_topic_score_gemma":0.000233945,"domain_scores_codex":[0.999081,0.00002523092,0.000224989,0.0002846851,0.0001701098,0.0002140039],"domain_scores_gemma":[0.999619,0.00001805838,0.0001136811,0.0001387678,0.00003686464,0.00007362419],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0000883274,0.0001039899,0.009155273,0.0000755822,0.00003653339,0.000005229492,0.00021716,0.001523965,0.9870226,0.00001562627,0.0002263028,0.001529419],"study_design_scores_gemma":[0.001397255,0.000117561,0.02268467,0.00006365844,0.00001868733,0.000001179309,0.0002548708,0.0007119532,0.9743016,0.00002941469,0.0002780324,0.0001411208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964938,0.001055107,0.0007724345,0.0002601559,0.00004096061,0.0001571171,0.000132632,0.000004871597,0.001082904],"genre_scores_gemma":[0.9986582,0.0003350255,0.00007725422,0.0001291223,0.0001488508,0.00002660711,0.0001293209,0.00001877506,0.0004768007],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0135294,"threshold_uncertainty_score":0.4583641,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4414228279","doi":"10.1158/2643-3230.bcd-25-0280","title":"Perspectives on Newly Diagnosed Myeloma Treatment and Emerging Challenges","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Multiple myeloma; Immunotherapy; MEDLINE; Clinical Practice; Daratumumab; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.02618619994958432,"gpt":0.329213792396261,"spread":0.3030275924466767,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004377633,0.000208147,0.0002971054,0.0001686662,0.0001097178,0.0000475753,0.0000487822,0.00004261676,0.00004637608],"category_scores_gemma":[0.00004792705,0.0001512131,0.00009246697,0.0001240694,0.00007451271,0.0001217181,0.00003947225,0.00008943005,0.000007494595],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002198263,"about_ca_system_score_gemma":0.0002193314,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008956054,"about_ca_topic_score_gemma":0.00051057,"domain_scores_codex":[0.9988917,0.00003909353,0.000124589,0.0004525043,0.0001829605,0.0003091429],"domain_scores_gemma":[0.999383,0.0001216828,0.0000309333,0.0002977811,0.00003804774,0.0001285018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002749421,0.004950325,0.1652764,0.0004328876,0.004990797,0.001005787,0.006149672,0.0000274537,0.004308423,0.01227809,0.0005826379,0.7972481],"study_design_scores_gemma":[0.0455494,0.003798051,0.897307,0.001509022,0.001329512,0.00003221584,0.01268415,0.0001152478,0.02772329,0.000532066,0.008932874,0.0004871382],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9190212,0.0630238,0.000007912458,0.005679659,0.00009310431,0.0005373016,0.00004046815,0.00005025467,0.01154631],"genre_scores_gemma":[0.9429249,0.05188679,0.00007547711,0.000141096,0.0001593427,0.0003434426,0.00001042612,0.00001717482,0.004441311],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7967609,"threshold_uncertainty_score":0.6166291,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4416198715","doi":"10.1158/2643-3230.bcd-25-0408","title":"The Global State of Blood Cancers: An Ongoing Challenge","year":2025,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"State (computer science); Cancer; Field (mathematics); Toll; Cancer treatment","retraction":null,"screen_n_in":null,"score":{"opus":0.03640625996574852,"gpt":0.345158677566221,"spread":0.3087524176004725,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002437347,0.0002057792,0.0003668211,0.00004486918,0.0001839883,0.00008260581,0.0003001924,0.00006332147,0.00001907507],"category_scores_gemma":[0.00005387158,0.0001503287,0.0001495666,0.000453689,0.000175793,0.000391472,0.0001049734,0.0001860485,0.000001807374],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002411631,"about_ca_system_score_gemma":0.001485259,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00749364,"about_ca_topic_score_gemma":0.0130496,"domain_scores_codex":[0.9982847,0.00004804316,0.0003964718,0.0003788842,0.0004437595,0.0004481186],"domain_scores_gemma":[0.9989466,0.00005722869,0.0001593857,0.0005592096,0.0001589522,0.0001185996],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004585519,0.001493433,0.6201393,0.00158537,0.006241883,0.0003772537,0.002036939,0.00211488,0.007222752,0.02604737,0.004819998,0.3233353],"study_design_scores_gemma":[0.03883526,0.009359932,0.6352735,0.01811215,0.01777094,0.0002937829,0.01285269,0.001528874,0.1310757,0.03432254,0.09742186,0.003152804],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9432356,0.04079447,0.0001312799,0.001839875,0.0005199559,0.0003770589,0.0001495689,0.00005531491,0.01289689],"genre_scores_gemma":[0.9910355,0.00658528,0.00009905607,0.0008265486,0.0002210446,0.00008781005,0.000008253748,0.00001373849,0.001122816],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3201825,"threshold_uncertainty_score":0.9991155,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3106693055","doi":"10.1158/2643-3249.lymphoma20-ia08","title":"Abstract IA08: The role of gene expression in the classification of aggressive B-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Gene expression profiling; B cell; Immunophenotyping; Computational biology; Follicular lymphoma; Cancer research; Oncology; Biology; Medicine; Gene; Internal medicine; Immunology; Gene expression; Genetics; Antigen; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.01838753245647009,"gpt":0.2569584069591793,"spread":0.2385708745027092,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007075074,0.0001081101,0.0002109356,0.00002324779,0.00002926876,0.0000129512,0.0001507679,0.00004687921,0.00002545565],"category_scores_gemma":[0.00003143288,0.00005389646,0.0001059478,0.0001536364,0.00006242377,0.00008728787,0.00002460834,0.00004613915,0.000003077771],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000393925,"about_ca_system_score_gemma":0.0001917445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003627048,"about_ca_topic_score_gemma":0.0000261508,"domain_scores_codex":[0.9991125,0.00003930551,0.0002649557,0.0001796334,0.0002876311,0.0001159579],"domain_scores_gemma":[0.9991129,0.0001060778,0.0004182855,0.0002903341,0.00003707398,0.00003529626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004970547,0.003493067,0.260276,0.0002180787,0.0001529648,0.00005003889,0.004329477,0.0000588076,0.7124277,0.0001689058,0.001217358,0.01711059],"study_design_scores_gemma":[0.002336622,0.0001098313,0.4517437,0.0001747609,0.0001459237,0.000003347052,0.001236056,0.00002145095,0.543767,0.00002964271,0.0003920486,0.00003952609],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9824434,0.01300766,0.000003081158,0.001720612,0.00003536583,0.0003741463,0.00006772783,0.000005438623,0.002342573],"genre_scores_gemma":[0.9979388,0.001338387,0.00003610197,0.0003730845,0.0001106922,0.000154814,0.00002164626,0.00001015914,0.00001628974],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1914678,"threshold_uncertainty_score":0.2197834,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4392384615","doi":"10.1158/2643-3249.bcdsymp24-p19","title":"Abstract P19: Mitohormetic Regulation in Multiple Myeloma: Exploiting Mitochondrial Stress Responses for Therapeutic Gain","year":2024,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research; University Health Network","funders":"","keywords":"Multiple myeloma; Stress (linguistics); Medicine; Psychology; Internal medicine; Linguistics","retraction":null,"screen_n_in":null,"score":{"opus":0.04870299445471482,"gpt":0.3412102441585546,"spread":0.2925072497038397,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001799468,0.0002397662,0.0003243216,0.0003098894,0.00009549267,0.0001835573,0.0000970423,0.00009379366,0.00007850964],"category_scores_gemma":[0.0002172599,0.000197659,0.0001915115,0.0002899867,0.00006605362,0.0004359952,0.00003320611,0.0002127524,0.00001504547],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002346354,"about_ca_system_score_gemma":0.0004826684,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008122706,"about_ca_topic_score_gemma":0.001140708,"domain_scores_codex":[0.9981039,0.00006789422,0.0003719472,0.000528192,0.0004061357,0.0005218872],"domain_scores_gemma":[0.9986638,0.0007938917,0.00005832873,0.0002922897,0.00005954383,0.0001321304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01536493,0.001973861,0.1938226,0.003308817,0.001928323,0.001003935,0.001353635,0.0007508323,0.6017194,0.0005142757,0.001253217,0.1770062],"study_design_scores_gemma":[0.0285982,0.0009222438,0.6224058,0.004961993,0.000827041,0.00005941864,0.0008858352,0.0114128,0.3252295,0.001223395,0.00273753,0.0007363004],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9870787,0.008432628,0.0005618713,0.001023703,0.0005550692,0.001598759,0.0004277037,0.0001014745,0.000220127],"genre_scores_gemma":[0.9952193,0.0003640211,0.0005885533,0.00006752679,0.0009040306,0.001120321,0.0001816813,0.00006436695,0.001490159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4285832,"threshold_uncertainty_score":0.80603,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4367603663","doi":"10.1158/2643-3249.aml23-a16","title":"Abstract A16: Multi-omic analyses in genetically engineered mice reveal distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells","year":2023,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Biology; IDH2; Haematopoiesis; Isocitrate dehydrogenase; Epigenetics; Progenitor cell; Myeloid; DNA methylation; Myeloid leukemia; Stem cell; Cancer research; IDH1; Genetics; Mutation; Gene; Gene expression; Enzyme; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02629545926025301,"gpt":0.3194442679006793,"spread":0.2931488086404263,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001807181,0.0002131525,0.0004910743,0.0003671439,0.00003418303,0.00004423627,0.00008095122,0.0001101856,0.000002843052],"category_scores_gemma":[0.00008092564,0.0001913126,0.00005154198,0.000530203,0.0001717861,0.0001391306,0.0001175993,0.0002555159,0.00000199708],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001388447,"about_ca_system_score_gemma":0.0003607776,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006751817,"about_ca_topic_score_gemma":0.0003640685,"domain_scores_codex":[0.9984949,0.00006394552,0.0004063343,0.0004302103,0.0002416688,0.0003629792],"domain_scores_gemma":[0.9991472,0.0003670225,0.00007745404,0.0002001227,0.00004180047,0.0001663353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.000190974,0.0001642009,0.09458684,0.00295132,0.0001827923,0.0003639781,0.0007191414,0.0001564068,0.8988075,0.00000435928,0.00003892197,0.001833569],"study_design_scores_gemma":[0.005528568,0.0001465355,0.7478862,0.0007242764,0.0003356325,0.00005098215,0.0002466065,0.002051036,0.2428172,0.00001439796,0.000005975857,0.0001925874],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990924,0.007735746,0.00002375159,0.0002021538,0.00004392847,0.0009462688,0.00008713189,0.00002549921,0.00001152918],"genre_scores_gemma":[0.9977375,0.001484005,0.0002599257,0.0000292087,0.00004894465,0.0001708982,0.00002092581,0.00003792171,0.0002107225],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6559903,"threshold_uncertainty_score":0.7801502,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4392366857","doi":"10.1158/2643-3249.bcdsymp24-p11","title":"Abstract P11: ARID1A mutations shape memory B-cell dynamics and confer sensitivity to SWI/SNF remodeling complex inhibition in lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"ARID1A; SWI/SNF; Chromatin remodeling; Cancer research; Dynamics (music); Biology; Genetics; Cell biology; Mutation; Chemistry; Transcription factor; Gene; Physics","retraction":null,"screen_n_in":null,"score":{"opus":0.01354354032674164,"gpt":0.2643173962480908,"spread":0.2507738559213492,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001640341,0.0001928658,0.0001746897,0.00008131067,0.00006974311,0.0001497032,0.00003886156,0.0001252736,0.00001882858],"category_scores_gemma":[0.00001732176,0.0002025388,0.00007463992,0.0001314457,0.00005047129,0.00002659186,0.00008262527,0.00009456647,0.000005311076],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001059322,"about_ca_system_score_gemma":0.0003072666,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001044492,"about_ca_topic_score_gemma":0.003060234,"domain_scores_codex":[0.9987848,0.00003279439,0.0002535557,0.0005089233,0.0001422384,0.0002776721],"domain_scores_gemma":[0.9995913,0.00002461733,0.00004188266,0.0002002552,0.00005155264,0.00009042989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.00008324208,0.0001618418,0.0005546877,0.0003228416,0.00006703913,0.00005419139,0.0002704621,0.03581373,0.9312497,0.00008590375,0.0004342227,0.03090211],"study_design_scores_gemma":[0.003517415,0.0002198934,0.02189212,0.001167628,0.0002623903,0.000149833,0.001244274,0.6484472,0.3197883,0.0004246192,0.001542491,0.001343865],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926444,0.002592974,0.002639196,0.0003291505,0.0001973134,0.0002068963,0.0003170259,0.00003242448,0.001040669],"genre_scores_gemma":[0.9976444,0.0006533584,0.0003004019,0.0004399075,0.0002472553,0.00004277426,0.0003619819,0.00003778799,0.0002721347],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6126335,"threshold_uncertainty_score":0.8259291,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3110051212","doi":"10.1158/2643-3249.lymphoma20-ia42","title":"Abstract IA42: Detecting and quantifying mutations associated with treatment resistance in aggressive lymphomas using ctDNA","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Discovery","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; Queen's University; McGill University; Simon Fraser University","funders":"","keywords":"Oncology; Exome sequencing; Exome; Medicine; Precision medicine; Internal medicine; Diffuse large B-cell lymphoma; Lymphoma; Population; Digital polymerase chain reaction; Rituximab; Bioinformatics; Biology; Mutation; Pathology; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.03169157068812597,"gpt":0.2752715269306022,"spread":0.2435799562424762,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000353555,0.0001542462,0.0001643603,0.00002571889,0.00009208226,0.00007661396,0.00005735563,0.00006784913,0.0000032276],"category_scores_gemma":[0.0001188689,0.0001440279,0.00003881061,0.0001204821,0.0000507916,0.00001321326,0.00003756406,0.00004960741,2.182148e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008687477,"about_ca_system_score_gemma":0.0002980728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005260413,"about_ca_topic_score_gemma":0.010049,"domain_scores_codex":[0.9991819,0.00001804655,0.0001671508,0.0003473469,0.0000797837,0.000205779],"domain_scores_gemma":[0.9995503,0.00004360762,0.0001899589,0.000113858,0.00003290429,0.00006931532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008895511,0.0004024146,0.2938741,0.000163989,0.0008453893,0.0003027229,0.001906903,0.01297433,0.6840863,0.0001276654,0.00007635137,0.004350331],"study_design_scores_gemma":[0.01535504,0.001323961,0.2825691,0.001552566,0.0008649171,0.00003162672,0.001834136,0.001179098,0.6915872,0.0002082082,0.001769618,0.001724542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904196,0.00878382,0.00009808654,0.0001445556,0.00004692267,0.0001652338,0.0001636099,0.000007580687,0.0001705951],"genre_scores_gemma":[0.9980532,0.001270431,0.000227537,0.0001775345,0.0001322011,0.00003814355,0.00004998638,0.00002639413,0.00002456046],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01446549,"threshold_uncertainty_score":0.5873286,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}